ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics Inc (GLUE)

5,43
-0,24
( -4,23% )
Aktualisiert: 18:13:18
Fortg. Diagramm

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
5,43
Gebot
5,42
Fragen
5,44
Volumen
285.157
5,40 Tagesbereich 5,95
3,21 52-Wochen-Bereich 12,40
Marktkapitalisierung
Handelsende
5,67
Handelsbeginn
5,82
Letzte Trade
26
@
5.43
Letzter Handelszeitpunkt
18:13:20
Finanzvolumen
US$ 1.611.502
VWAP
5,6513
Durchschnittliches Volumen (3 Mio.)
737.219
Ausgegebene Aktien
61.436.740
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,46
Gewinn pro Aktie (EPS)
-2,2
Erlöse
-
Nettogewinn
-135,35M

Über Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enable... Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Monte Rosa Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker GLUE. The last closing price for Monte Rosa Therapeutics was US$5,67. Over the last year, Monte Rosa Therapeutics shares have traded in a share price range of US$ 3,21 to US$ 12,40.

Monte Rosa Therapeutics currently has 61.436.740 shares in issue. The market capitalisation of Monte Rosa Therapeutics is US$348,35 million. Monte Rosa Therapeutics has a price to earnings ratio (PE ratio) of -2.46.

GLUE Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.24-18.59070464776.677.315.413727326.35321656CS
4-0.51-8.585858585865.947.315.257736056.23934162CS
12-1.548-22.18400687886.9787.455.157372196.20871265CS
26-0.24-4.23280423285.6712.44.59517192348.37901211CS
52-3.12-36.49122807028.5512.43.219646097.96898837CS
156-5.79-51.604278074911.2215.5252.444492107.66267429CS
260-16.57-75.31818181822245.562.444097609.27154198CS

GLUE - Frequently Asked Questions (FAQ)

What is the current Monte Rosa Therapeutics share price?
The current share price of Monte Rosa Therapeutics is US$ 5,43
How many Monte Rosa Therapeutics shares are in issue?
Monte Rosa Therapeutics has 61.436.740 shares in issue
What is the market cap of Monte Rosa Therapeutics?
The market capitalisation of Monte Rosa Therapeutics is USD 348,35M
What is the 1 year trading range for Monte Rosa Therapeutics share price?
Monte Rosa Therapeutics has traded in the range of US$ 3,21 to US$ 12,40 during the past year
What is the PE ratio of Monte Rosa Therapeutics?
The price to earnings ratio of Monte Rosa Therapeutics is -2,46
What is the reporting currency for Monte Rosa Therapeutics?
Monte Rosa Therapeutics reports financial results in USD
What is the latest annual profit for Monte Rosa Therapeutics?
The latest annual profit of Monte Rosa Therapeutics is USD -135,35M
What is the registered address of Monte Rosa Therapeutics?
The registered address for Monte Rosa Therapeutics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Monte Rosa Therapeutics website address?
The website address for Monte Rosa Therapeutics is www.monterosatx.com.
Which industry sector does Monte Rosa Therapeutics operate in?
Monte Rosa Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PTPIPetros Pharmaceuticals Inc
US$ 0,189
(226,99%)
1,33B
OSRHOSR Holdings Inc
US$ 3,42
(113,75%)
73,39M
OCEAOcean Biomedical Inc
US$ 0,1111
(95,60%)
463,95M
VVPRVivoPower International PLC
US$ 4,04
(78,76%)
127,99M
SURGSurgePays Inc
US$ 2,205
(59,78%)
63,01M
BACKIMAC Holdings Inc
US$ 0,071
(-64,50%)
1,13M
ACRVAcrivon Therapeutics Inc
US$ 3,28
(-39,15%)
895,24k
HUMAHumacyte Inc
US$ 2,015
(-29,91%)
16,54M
TNONTenon Medical Inc
US$ 2,6978
(-28,06%)
16,2M
BHILBenson Hill Inc
US$ 0,3059
(-27,75%)
679,06k
PTPIPetros Pharmaceuticals Inc
US$ 0,189
(226,99%)
1,33B
OCEAOcean Biomedical Inc
US$ 0,1111
(95,60%)
463,95M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,0704
(39,13%)
194,02M
NVDANVIDIA Corporation
US$ 113,4399
(-6,01%)
177,64M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,39
(-12,32%)
154,19M

GLUE Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock